{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:19:40Z","timestamp":1764260380879,"version":"3.30.2"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:00:00Z","timestamp":1728086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejmg.2024.104976","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T14:58:01Z","timestamp":1728140281000},"page":"104976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Lessons learned from the RE(ACT) conference on medical devices for rare diseases"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5883-7610","authenticated-orcid":false,"given":"Anneliene H.","family":"Jonker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Buckinx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Pannese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulien","family":"Klap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9-Alain","family":"Sahel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Dooms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.ejmg.2024.104976_bib1","article-title":"Development and validation of a novel mobility test for rod-cone dystrophies, from reality to virtual reality","volume":"Jul 10;S0002\u20139394","author":"Authi\u00e9","year":"2023","journal-title":"Am. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ejmg.2024.104976_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014931","article-title":"Innovative approach for self-management and social welfare of children with cystic fibrosis in Europe: development, validation and implementation of an mHealth tool (MyCyFAPP)","volume":"7","author":"Calvo-Lerma","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejmg.2024.104976_bib3","unstructured":"Commissioner O of the. FDA. FDA; 2023 [cited 2023 Sep 29], Humanitarian use device designation program. Available from: https:\/\/www.fda.gov\/industry\/medical-products-rare-diseases-and-conditions\/humanitarian-use-device-hud-designation-program."},{"issue":"3","key":"10.1016\/j.ejmg.2024.104976_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.29245\/2572-9411\/2016\/3.1058","article-title":"Orphan devices for the surgical treatment of patients with rare diseases: present status and recommendations for the future","volume":"1","author":"Dooms","year":"2016","journal-title":"J. Rare Dis. Res. Treat."},{"issue":"1","key":"10.1016\/j.ejmg.2024.104976_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13023-023-02685-7","article-title":"Orphan medical devices have come a long way","volume":"18","author":"Dooms","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ejmg.2024.104976_bib6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13023-023-02801-7","article-title":"Gaps in the evidence underpinning high-risk medical devices in Europe at market entry, and potential solutions","volume":"18","author":"Hulstaert","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ejmg.2024.104976_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12984-021-00868-6","article-title":"Feasibility and effectiveness of a novel dynamic arm support in persons with spinal muscular atrophy and duchenne muscular dystrophy","volume":"18","author":"Janssen","year":"2021","journal-title":"J. NeuroEng. Rehabil."},{"issue":"S4","key":"10.1016\/j.ejmg.2024.104976_bib8","first-page":"S40","article-title":"Automated detection of absence seizures using a wearable electroencephalographic device: a phase 3 validation study and feasibility of automated behavioral testing","volume":"64","author":"Japaridze","year":"2022","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.ejmg.2024.104976_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12984-015-0072-y","article-title":"Design and pilot validation of A-gear: a novel wearable dynamic arm support","volume":"12","author":"Kooren","year":"2015","journal-title":"J. NeuroEng. Rehabil."},{"issue":"26","key":"10.1016\/j.ejmg.2024.104976_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000866","article-title":"Rod-derived cone viability factor for treating blinding diseases: from clinic to redox signaling","volume":"2","author":"L\u00e9veillard","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmg.2024.104976_bib11","unstructured":"Listing of CDRH Humanitarian Device Exemptions FDA [Internet]. [cited 2022 Mar 2]. Available from: https:\/\/www.fda.gov\/medical-devices\/hde-approvals\/listing-cdrh-humanitarian-device-exemptions."},{"journal-title":"Med. Dev.","article-title":"MDCG 2024-10 Clinical evaluation of orphan medical devices","year":"2024","key":"10.1016\/j.ejmg.2024.104976_bib12"},{"issue":"2","key":"10.1016\/j.ejmg.2024.104976_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00246-022-03029-1","article-title":"Orphan medical devices and pediatric cardiology - what interventionists in Europe need to know, and what needs to be done","volume":"44","author":"Melvin","year":"2023","journal-title":"Pediatr Cardiol"},{"issue":"10213","key":"10.1016\/j.ejmg.2024.104976_bib13","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","article-title":"Muscular dystrophies","volume":"394","author":"Mercuri","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejmg.2024.104976_bib14","unstructured":"Ministry of Health, Labour and Welfare: Pharmaceuticals and Medical Devices [Internet]. [cited 2022 Mar 3]. Available from: https:\/\/www.mhlw.go.jp\/english\/policy\/health-medical\/pharmaceuticals\/orphan_drug.html."},{"key":"10.1016\/j.ejmg.2024.104976_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/digm.digm_2_19","article-title":"Developing serious games to improve children's compliance in chronic illnesses: input from two use cases","volume":"5","author":"Morganti","year":"2019","journal-title":"Digit. Med."},{"issue":"4","key":"10.1016\/j.ejmg.2024.104976_bib16","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/brain\/awac421","article-title":"Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy","volume":"146","author":"Newman","year":"2023","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ejmg.2024.104976_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41467-022-28125-x","article-title":"Simultaneous perception of prosthetic and natural vision in AMD patients","volume":"13","author":"Palanker","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ejmg.2024.104976_bib18","first-page":"347011","article-title":"Children and adults with rare diseases need innovative medical devices","volume":"12","author":"Peiris","year":"2018","journal-title":"J. Med. Dev. Trans. ASME"},{"key":"10.1016\/j.ejmg.2024.104976_bib19","unstructured":"Progetto [Internet]. [cited 2023 Sep 25]. Available from: https:\/\/www.mycyfapp.eu\/index.php\/it\/."},{"key":"10.1016\/j.ejmg.2024.104976_bib20","unstructured":"React-congress [Internet]. [cited 2023 Sep 25]. RE(ACT) Congress. Available from: https:\/\/www.react-congress.org\/."},{"volume":"5","journal-title":"OJ L Apr","year":"2017","key":"10.1016\/j.ejmg.2024.104976_bib22"},{"key":"10.1016\/j.ejmg.2024.104976_bib23","unstructured":"REHABILITY: rehabilitation games co-designed with patients [Internet]. [cited 2023 Sep 25]. Available from: http:\/\/www.rehability.me\/#gallery."},{"issue":"7705","key":"10.1016\/j.ejmg.2024.104976_bib24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41586-018-0076-4","article-title":"Restoring vision","volume":"557","author":"Roska","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ejmg.2024.104976_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13023-017-0631-3","article-title":"The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review","volume":"12","author":"Ryder","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"494","key":"10.1016\/j.ejmg.2024.104976_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2324","article-title":"Depicting brighter possibilities for treating blindness","volume":"11","author":"Sahel","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmg.2024.104976_bib27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajo.2021.04.013","article-title":"Assessing photoreceptor status in retinal dystrophies: from high-resolution imaging to functional vision","volume":"230","author":"Sahel","year":"2021","journal-title":"Am. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.ejmg.2024.104976_bib28","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s41591-021-01351-4","article-title":"Partial recovery of visual function in a blind patient after optogenetic therapy","volume":"27","author":"Sahel","year":"2021","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ejmg.2024.104976_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13023-021-02133-4","article-title":"Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy","volume":"17","author":"Vijapurapu","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"573","key":"10.1016\/j.ejmg.2024.104976_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz7423","article-title":"Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy","volume":"12","author":"Yu-Wai-Man","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmg.2024.104976_bib32","unstructured":"Yumen Bionics [Internet]. [cited 2023 Sep 29]. Available from: https:\/\/www.parentprojectproductions.nl\/yumen-bionics\/."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721224000685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721224000685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T08:45:26Z","timestamp":1734425126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721224000685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":31,"alternative-id":["S1769721224000685"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2024.104976","relation":{},"ISSN":["1769-7212"],"issn-type":[{"type":"print","value":"1769-7212"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lessons learned from the RE(ACT) conference on medical devices for rare diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2024.104976","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104976"}}